Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy

FEMS Immunology and Medical Microbiology

Volumn 38, Issue 3, 2003, Pages 249-256

  Al Attiyah, R ^a   Mustafa, A S ^a   Abal, A T ^a   Madi, N M ^a   Andersen, P ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Chemotherapy; Interferon secretion; Peripheral blood mononuclear cell; Proliferation; Tuberculosis

Indexed keywords

CONCANAVALIN A; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; RECOMBINANT ANTIGEN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; CELL PROLIFERATION; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOASSAY; LUNG TUBERCULOSIS; MONONUCLEAR CELL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0042144735     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00166-4     Document Type: Article

References (29)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. J. Am. Med. Assoc. 282:1999;677-686.
2. Fatkenheuer G., Taelman H., Lepage P., Schwenk A., Wenzel R. The return of tuberculosis. Diag. Microbiol. Infect. Dis. 34:1999;139-146.
3. Espinal M.A., Laszlo A., Simonsen L., Boulahbal F., Kim S.J., Reniero A., Hoffner S., Rieder H.L., Binkin N., Dye C., Williams R., Raviglione M.C. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New Engl. J. Med. 344:2001;1294-1303.
4. Stenger S., Modlin R.L. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2:1999;89-93.
5. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19:2001;93-129.
6. Boesen H., Jensen B.N., Wilcke T., Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 63:1995;1491-1497.
7. Demissie A., Ravn P., Olobo J., Doherty T.M., Eguale T., Geletu M., Hailu W., Andersen P., Britton S. T-cell recognition of Mycobacterium tuberculosis culture filtrate in tuberculosis patients and their household contacts. Infect. Immun. 67:1999;5967-5971.
8. Hirsch C.S., Toossi Z., Othieno C., Johnson J.L., Schwander S.K., Robertson S., Wallis R.S., Edmonds K., Okwera A., Mugerwa R., Pete P., Ellner J.J. Depressed T cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180:1999;2069-2073.
9. Turner J., Corrah T., Sabbally S., Whittle H., Dochrell H.M. A longitudinal study of in vitro IFN-gamma and cytotoxic T cell responses of tuberculosis patients in the Gambia. Tuberc. Lung Dis. 80:2000;161-169.
10. Shams H., Wizel B., Weis S.E., Samten B., Barnes P.F. Contribution of CD8+ T cells to gamma interferon production in human tuberculosis. Infect. Immun. 69:2001;3497-3501.
11. Garcia M., Vargas J.A., Castejon R., Navas E., Durantez A. Flow cytometric assessment of lymphocyte cytokine production in tuberculosis. Tuberculosis. 82:2002;37-41.
12. Wilkinson R.J., Vordermeier H.M., Wilkinson K.A., Sjolund A., Moreno C., Pasvol G., Ivani J. Peptide-specific T cell responses to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 178:1998;760-768.
13. Dieli F., Friscia G., Di Sano C., Ivanyi J., Singh M., Spallek R., Sireci G., Titone L., Salerno A. Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J. Infect. Dis. 180:1999;225-228.
14. Ulrichs T., Anding R., Kaufmann S.H., Munk M.E. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int. J. Tuberc. Lung Dis. 4:2000;1181-1183.
15. Mustafa A.S., Lundin K.E.A., Oftung F. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae. Infect. Immun. 61:1993;5294-5301.
16. Oftung F., Geluk A., Lundin K.E.A., Meloen R.H., Thole J.E.R., Mustafa A.S., Ottenhoff T.H.M. Mapping of multiple HLA class II restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein. Infect. Immun. 62:1994;5411-5418.
17. Mustafa A.S., Lundin K.E.A., Meloen R.H., Shinnick T.M., Oftung F. Identification of promiscuous epitopes from the mycobacterial 65-kilodalton heat shock protein (HSP65) recognised by human CD4+ T cells of the Mycobacterium leprae memory repertoire. Infect. Immun. 67:1999;5683-5689.
18. Stratton M.A., Reed M.T. Short-course drug therapy for tuberculosis. Clin. Pharm. 5:1986;977-987.
19. Mustafa A.S., Oftung F. Long lasting T cell reactivity Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae. Vaccine. 11:1993;1108-1112.
20. Mustafa A.S., Shaban F., Abal A.T., Al-Attiyah R., Wiker H.G., Lundin K.E.A., Oftung F., Huygen K. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognised by antigen-specific human CD4+ T cell lines. Infect. Immun. 68:2000;3933-3940.
21. Andersen P., Askgaard D., Gottschau A., Bennedsen J., Nagai S., Heron I. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand. J. Immunol. 36:1992;823-831.
22. Mustafa A.S., Shaban F.A., Al-Attiyah R., Abal A.T., El-Shamy A.M., Andersen P., Oftung F. Human Th1 cell lines recognise the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand. J. Immunol. 57:2003;125-134.
23. Al-Attiyah R., Shaban F.A., Wiker H.G., Oftung F., Mustafa A.S. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect. Immun. 71:2003;1953-1960.
24. Mustafa A.S., Godal T. In vitro induction of human suppressor T cells by mycobacterial antigens. BCG activated OKT4+ cells mediate suppression of antigen-induced T cell proliferation. Clin. Exp. Immunol. 52:1983;29-37.
25. Mustafa A.S., Amoudy H.A., Wiker H.G., Abal A.T., Ravn P., Oftung F., Andersen P. Comparison of antigen specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand. J. Immunol. 48:1998;535-543.
26. Andersen P., Andersen A.B., Sorensen A.L., Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:1995;3359-3372.
27. McDyer J.F., Hackley M.N., Walsh T.E., Cook J.L., Seder R.A. Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J. Immunol. 158:1997;492-500.
28. Olsen A.W., Hansen P.R., Holm A., Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur. J. Immunol. 30:2000;1724.
29. Berthet F.X., Rasmussen P.B., Rosenkrands I., Andersen P., Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology. 144:1998;3195-3203.